Nonprofit revives gene therapy shelved after startup shut down
โฎ BeforeThe lead gene therapy was shelved when Bloomsbury Genetic Therapies shut down.
โ
NowA nonprofit is resurrecting the program.
In short
- Bloomsbury Genetic Therapies, a U.K. gene therapy startup, announced it was shutting down last year.
- The company had dosed just one patient before it closed.
- A nonprofit is now resurrecting the company's lead program.
Why it's good news
The startup closed after dosing one patient, which could have ended the program. A nonprofit is now taking the lead program up again. The source does not give the trial stage or the condition treated, so the path to patients is not yet clear.
Advertisement
From STAT
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:
Ask this story
More like this
Advertisement